Analysed HALOZYME THERAPEUTICS INC (HALO:NASDAQ) News Sources
Is Halozyme’s EU Injunction on Subcutaneous Keytruda Reshaping the Investment Case For Merck (MRK)?
07-10-2026
yahoo.com
Strength Seen in Halozyme Therapeutics (HALO): Can Its 3.3% Jump Turn into More Strength?
23-09-2026
yahoo.com
Unpacking Q2 Earnings: Halozyme Therapeutics (NASDAQ:HALO) In The Context Of Other Therapeutics Stocks
01-10-2026
yahoo.com
Merck’s Keytruda Is Dealt a Legal Setback. It’s Good News for This Biotech Stock.
07-10-2026
yahoo.com
What is the current price of HALOZYME THERAPEUTICS INC (HALO:NASDAQ)?
The current price of HALOZYME THERAPEUTICS INC (HALO:NASDAQ) is $110.42.
HALOZYME THERAPEUTICS INC (HALO:NASDAQ) absolute price change since previous trading day?
The absolute price change of HALOZYME THERAPEUTICS INC (HALO:NASDAQ) since the previous trading day is $0.58.
HALOZYME THERAPEUTICS INC (HALO:NASDAQ) percentage price change since previous trading day?
The percentage price change of HALOZYME THERAPEUTICS INC (HALO:NASDAQ) since the previous trading day is 0.528%.
What is the most recent average sentiment score for HALOZYME THERAPEUTICS INC (HALO:NASDAQ)?
The most recent average sentiment score for HALOZYME THERAPEUTICS INC (HALO:NASDAQ) is 73 out of 100.
What is the most recent average sentiment for HALOZYME THERAPEUTICS INC (HALO:NASDAQ)?
The most recent sentiment for HALOZYME THERAPEUTICS INC (HALO:NASDAQ) is .
SEC-8K** Filing Available For HALOZYME THERAPEUTICS INC (HALO:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.